Cargando…

Adalimumab Reduces Extraintestinal Manifestations in Patients with Crohn’s Disease: A Pooled Analysis of 11 Clinical Studies

INTRODUCTION: Extraintestinal manifestations (EIMs) in patients with Crohn’s disease (CD) are common and associated with additional morbidity. This study aimed to evaluate the effect of adalimumab therapy on EIM resolution and identify potential predictors of EIM resolution in adult and pediatric pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Louis, Edouard J., Reinisch, Walter, Schwartz, David A., Löfberg, Robert, Robinson, Anne M., Berg, Sofie, Wang, Anthony W., Maa, Jen-fue, Huang, Bidan, Pappalardo, Brandee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5910478/ https://www.ncbi.nlm.nih.gov/pubmed/29516410 http://dx.doi.org/10.1007/s12325-018-0678-0

Ejemplares similares

Efficacy and Safety of Adalimumab by Disease Duration: Analysis of Pooled Data From Crohn’s Disease Studies
por: Panaccione, Remo, et al.
Publicado: (2019)

Clinical Benefit of Long-Term Adalimumab Treatment in Patients With Crohn’s Disease Following Loss of Response or Intolerance to Infliximab: 96-Week Efficacy Data From GAIN/ADHERE Trials
por: Panaccione, Remo, et al.
Publicado: (2018)

Extraintestinal manifestations of Crohn’s disease
por: Wójcik, Bartosz, et al.
Publicado: (2016)

Leukocytoclastic Vasculitis as an Extraintestinal Manifestation of Crohn's Disease
por: Rocha, Thiara Barcelos, et al.
Publicado: (2021)

Adalimumab Effectiveness Up to Six Years in Adalimumab-naïve Patients with Crohn’s Disease: Results of the PYRAMID Registry
por: Loftus, Edward V, et al.
Publicado: (2019)

The impact of ustekinumab on extraintestinal manifestations of Crohn's disease: A post hoc analysis of the UNITI studies
por: Narula, Neeraj, et al.
Publicado: (2021)

Clinical Features and Extraintestinal Manifestations of Crohn Disease in Children
por: Lee, Young Ah, et al.
Publicado: (2016)

Hidradenitis suppurativa: Coexistence or dermatological extraintestinal manifestation of Crohn's disease?
por: Luporini, Rafael Luís, et al.
Publicado: (2023)

Efficacy of Adalimumab for Treatment of Perianal Fistula in Children with Moderately to Severely Active Crohn’s Disease: Results from IMAgINE 1 and IMAgINE 2
por: Ruemmele, Frank M, et al.
Publicado: (2018)

Extraintestinal Manifestations of Crohn’s Disease in the Form of Pulmonary Nodules: A Case Report
por: Garg, Chandi, et al.
Publicado: (2020)

494. Enteric bacteria are immune-reactive in patients with Crohn's disease with extraintestinal manifestations
por: Maldarelli, Grace A, et al.
Publicado: (2022)

Altered Markers of Brain Development in Crohn’s Disease with Extraintestinal Manifestations – A Pilot Study
por: Thomann, Anne K., et al.
Publicado: (2016)

A case of previously undiagnosed Crohn’s disease presenting with acute pancreatitis as an extraintestinal manifestation
por: Bolukbas, F. Fusun, et al.
Publicado: (2005)

Adalimumab in Crohn’s disease
por: Van Assche, Gert, et al.
Publicado: (2007)

Extraintestinal manifestations at baseline, and the effect of tofacitinib, in patients with moderate to severe ulcerative colitis
por: Rubin, David T., et al.
Publicado: (2021)

Extraintestinal Manifestations of Inflammatory Bowel Disease
por: Vavricka, Stephan R., et al.
Publicado: (2015)

Autoantibodies in the Extraintestinal Manifestations of Celiac Disease
por: Yu, Xuechen B., et al.
Publicado: (2018)

Extraintestinal Manifestations of Inflammatory Bowel Disease
por: Al-Quorain, Abdulaziz A.
Publicado: (2019)

Efficacy and Safety of Escalation of Adalimumab Therapy to Weekly Dosing in Pediatric Patients with Crohn's Disease
por: Dubinsky, Marla C., et al.
Publicado: (2016)

Discriminating Potential of Extraintestinal Systemic Manifestations and Colonoscopic Features in Chinese Patients with Intestinal Behçet's Disease and Crohn's Disease
por: Li, Ji, et al.
Publicado: (2015)

Adalimumab for the treatment of Crohn’s disease
por: Cassinotti, Andrea, et al.
Publicado: (2008)

Clinical Practice of Adalimumab and Infliximab Biosimilar Treatment in Adult Patients With Crohn’s Disease
por: Reinisch, Walter, et al.
Publicado: (2020)

Adalimumab for the treatment of fistulas in patients with Crohn’s disease
por: Colombel, J-F, et al.
Publicado: (2009)

Efficacy and safety of adalimumab in Chinese patients with moderately to severely active Crohn’s disease: results from a randomized trial
por: Chen, Baili, et al.
Publicado: (2020)

Extraintestinal Manifestations and Other Comorbidities in Ulcerative Colitis and Crohn Disease: A Danish Nationwide Registry Study 2003–2016
por: Vadstrup, Kasper, et al.
Publicado: (2020)

Efficacy and tolerability of fixed-dose amlodipine/olmesartan medoxomil with or without hydrochlorothiazide in Hispanic and non-Hispanic patients whose blood pressure is uncontrolled on antihypertensive monotherapy
por: Punzi, Henry, et al.
Publicado: (2012)

Skin gangrene as an extraintestinal manifestation of inflammatory bowel disease
por: Komatsu, Yumi Cristina, et al.
Publicado: (2014)

Importance of Extraintestinal Manifestations in Early Diagnosis of Gardner Syndrome
por: Besteiro, Bruno, et al.
Publicado: (2020)

Temporal Relationship of Extraintestinal Manifestations in Inflammatory Bowel Disease
por: Fedor, Istvan, et al.
Publicado: (2021)

Helicobacter pylori-Related Extraintestinal Manifestations—Myth or Reality
por: Mărginean, Cristian Dan, et al.
Publicado: (2022)

Extraintestinal Manifestations in Children Diagnosed with Inflammatory Bowel Disease
por: Kavcar, Zubeyr, et al.
Publicado: (2023)

Interstitial Lung Disease as an Extraintestinal Manifestation of Crohn’s Disease in the Time of COVID-19: A Rare Case Report and Review of the Literature
por: Li, Lin, et al.
Publicado: (2022)

Characterisation of Mucosal Healing with Adalimumab Treatment in Patients with Moderately to Severely Active Crohn’s Disease: Results from the EXTEND Trial
por: Reinisch, Walter, et al.
Publicado: (2017)

Management of Crohn’s disease in poor responders to adalimumab
por: de Boer, Nanne KH, et al.
Publicado: (2014)

Efficacy of Adalimumab in Korean Patients with Crohn’s Disease
por: Sohn, Il Woong, et al.
Publicado: (2016)

Development of a Risk Score for Extraintestinal Manifestations of Coeliac Disease
por: Chiu, Christine L., et al.
Publicado: (2016)

Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease
por: Fleisher, Mark, et al.
Publicado: (2018)

Intestinal parameters of oxidative imbalance in celiac adults with extraintestinal manifestations
por: Piatek-Guziewicz, Agnieszka, et al.
Publicado: (2017)

Prevalence of extraintestinal manifestations in Korean inflammatory bowel disease patients
por: Yang, Bo Ram, et al.
Publicado: (2018)

Dermatitis Herpetiformis: A Common Extraintestinal Manifestation of Coeliac Disease
por: Reunala, Timo, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_euen35nod0ksh89fbthba5rdbh